Legal Opinion
In Re Neopharm, Inc. Securities Litigation
District Court, N.D. Illinois
Decided March 31, 2010No. 02 C 2976PublishedCited by 2 opinions
1Opinion of the Court
OPINION AND ORDER
JOAN HUMPHREY LEFKOW, District Judge.
Plaintiffs, a class of persons who purchased the common stock of defendant, NeoPharm, Inc. (“NeoPharm”), between the dates of October 31, 2001 and April 19, 2002 (“the class period”), alleging that NeoPharm, John N. Kapoor (“Kapoor”), 1 James M. Hussey (“Hussey”), and Imran Ahmad (“Ahmad”) (collectively “defendants”), violated Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”), 15 U.S.C. § 780(b), and Rule 10b-5 promulgated thereunder, 17 C.F.R. § 240.10b-5, by knowingly or recklessly making false and misleading…
2Cases cited33 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Ernst & Ernst v. HochfelderSupreme Court of the United States · 1976
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
- Dura Pharmaceuticals, Inc. v. BroudoSupreme Court of the United States · 2005
28 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Sistrunk v. KhanDistrict Court, N.D. Illinois · 2013
- Silverman v. Motorola, Inc.District Court, N.D. Illinois · 2011